MétaCan
Menu
Back to cohort
Record W4381125429 · doi:10.1136/gutjnl-2023-bsg.136

P64 The impact of anti-TNF and thiopurine therapy on the natural history of Crohn’s disease: a population-based study

2023· article· en· W4381125429 on OpenAlexaboutno aff
Bradley Arms-Williams, A. B. Hawthorne, Rebecca Cannings‐John, Alexander Berry, Philip Harborne, Anjali Trivedi

Bibliographic record

VenuePoster presentations · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
Fundersnot available
KeywordsThiopurine methyltransferaseMedicineCrohn's diseaseNatural historyInternal medicineRetrospective cohort studyPopulationHazard ratioCohortConfoundingPropensity score matchingConfidence intervalSurgeryInflammatory bowel diseaseDisease

Abstract

fetched live from OpenAlex

<h3>Introduction</h3> It has been hard to demonstrate if early immunosuppression alters resection rates for Crohn’s disease (CD). We studied a population-based cohort from Cardiff to evaluate the impact of both anti-TNF therapy and thiopurines on the natural history of CD, including surgical resection rates. <h3>Methods</h3> This was a retrospective population-based cohort study of all patients diagnosed with CD whilst resident in Cardiff and nearby towns over 12 years 2005–2016. The primary outcome was the impact of therapy on the time to first resection surgery up to 5 years for patients receiving early sustained use (ESU): drug started within one year of diagnosis and continued at least 3 months, versus never use (NU). A propensity score (PS) was calculated. Inverse probability of treatment weighting (IPTW) based on the PS was used so that confounders (baseline Montreal classification, smoking, steroid use, serum albumin) was similar in both the treated and untreated groups. To address immortal time bias (ITB) if an outcome occurs after diagnosis but before the start of therapy, then this time segment is attributed to the untreated group. Therefore, <i>n</i> represents time segments, not individual patients, in statistical analyses. <h3>Results</h3> 419 CD cases were studied. With IPTW there was a significant reduction in risk of surgical resection with ESU anti-TNF vs NU (p=0.0026,<i> n</i>=460 (57 ESU vs 403 NU segments), hazard ratio (HR) 0.28, 95% confidence interval (CI) 0.12 to 0.62) but not with ESU thiopurine vs NU (p=0.39, <i>n</i>=545, HR 0.82, 95% CI 0.52 to 1.29). 138/419 patients received any anti-TNF therapy prior to resection, while 57 had ESU. Probability of avoiding surgery in ESU vs NU at 1 year (98% v 83%), 2 years (95% vs 80%), and 5 years (91% vs 75%). See figure 1. After 5 years the resection rates converged with wider CIs. <h3>Conclusions</h3> Strengths of our study include the individual patient detail conferred from hospital record data collection, contributing to a PS and IPTW to account for confounders, and removal of ITB. ITB artificially protracts treatment arm survival, therefore its removal portrays a more accurate comparison. With this, we demonstrate a significant reduction in surgical resection rates at 5 years in ESU anti-TNF therapy vs NU. Larger numbers are needed to analyse benefits beyond 5 years.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.304
Teacher spread0.284 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venuePoster presentationsSame topicInflammatory Bowel DiseaseFrench-language works237,207